Cargando…
A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study
INTRODUCTION: The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). METHODS: A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836711/ https://www.ncbi.nlm.nih.gov/pubmed/27092776 http://dx.doi.org/10.1371/journal.pone.0153316 |
_version_ | 1782427770090946560 |
---|---|
author | Vernerova, Lucia Spoutil, Frantisek Vlcek, Miroslav Krskova, Katarina Penesova, Adela Meskova, Milada Marko, Andrea Raslova, Katarina Vohnout, Branislav Rovensky, Jozef Killinger, Zdenko Jochmanova, Ivana Lazurova, Ivica Steiner, Guenter Smolen, Josef Imrich, Richard |
author_facet | Vernerova, Lucia Spoutil, Frantisek Vlcek, Miroslav Krskova, Katarina Penesova, Adela Meskova, Milada Marko, Andrea Raslova, Katarina Vohnout, Branislav Rovensky, Jozef Killinger, Zdenko Jochmanova, Ivana Lazurova, Ivica Steiner, Guenter Smolen, Josef Imrich, Richard |
author_sort | Vernerova, Lucia |
collection | PubMed |
description | INTRODUCTION: The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). METHODS: A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in the study. The presence of shared epitope (SE) in HLA-DRB1 and 11 SNPs (PTPN22 C/T (rs2476601), STAT4 G/T (rs7574865), CTLA4 A/G (rs3087243), TRAF1/C5 A/G (rs3761847), IRF5 T/C (rs10488631), TNFAIP3 C/T (rs5029937), AFF3 A/T (rs11676922), PADI4 C/T (rs2240340), CD28 T/C (rs1980422), CSK G/A (rs34933034) and FCGR3A A/C (rs396991), rheumatoid factor (RF), anti–citrullinated protein antibodies (ACPA) and clinical status was analysed using the LDA and RDA. RESULTS: HLA-DRB1, PTPN22, STAT4, IRF5 and PADI4 significantly discriminated between RA patients and healthy controls in LDA. The correlation between RA diagnosis and the explanatory variables in the model was 0.328 (Trace = 0.107; F = 13.715; P = 0.0002). The risk variants of IRF5 and CD28 genes were found to be common determinants for seropositivity in RDA, while positivity of RF alone was associated with the CTLA4 risk variant in heterozygous form. The correlation between serologic status and genetic determinants on the 1st ordinal axis was 0.468, and 0.145 on the 2nd one (Trace = 0.179; F = 6.135; P = 0.001). The risk alleles in AFF3 gene together with the presence of ACPA were associated with higher clinical severity of RA. CONCLUSIONS: The association among multiple risk variants related to T cell receptor signalling with seropositivity may play an important role in distinct clinical phenotypes of RA. Our study demonstrates that multiparametric analyses represent a powerful tool for investigation of mutual relationships of potential risk factors in complex diseases such as RA. |
format | Online Article Text |
id | pubmed-4836711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48367112016-04-29 A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study Vernerova, Lucia Spoutil, Frantisek Vlcek, Miroslav Krskova, Katarina Penesova, Adela Meskova, Milada Marko, Andrea Raslova, Katarina Vohnout, Branislav Rovensky, Jozef Killinger, Zdenko Jochmanova, Ivana Lazurova, Ivica Steiner, Guenter Smolen, Josef Imrich, Richard PLoS One Research Article INTRODUCTION: The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). METHODS: A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in the study. The presence of shared epitope (SE) in HLA-DRB1 and 11 SNPs (PTPN22 C/T (rs2476601), STAT4 G/T (rs7574865), CTLA4 A/G (rs3087243), TRAF1/C5 A/G (rs3761847), IRF5 T/C (rs10488631), TNFAIP3 C/T (rs5029937), AFF3 A/T (rs11676922), PADI4 C/T (rs2240340), CD28 T/C (rs1980422), CSK G/A (rs34933034) and FCGR3A A/C (rs396991), rheumatoid factor (RF), anti–citrullinated protein antibodies (ACPA) and clinical status was analysed using the LDA and RDA. RESULTS: HLA-DRB1, PTPN22, STAT4, IRF5 and PADI4 significantly discriminated between RA patients and healthy controls in LDA. The correlation between RA diagnosis and the explanatory variables in the model was 0.328 (Trace = 0.107; F = 13.715; P = 0.0002). The risk variants of IRF5 and CD28 genes were found to be common determinants for seropositivity in RDA, while positivity of RF alone was associated with the CTLA4 risk variant in heterozygous form. The correlation between serologic status and genetic determinants on the 1st ordinal axis was 0.468, and 0.145 on the 2nd one (Trace = 0.179; F = 6.135; P = 0.001). The risk alleles in AFF3 gene together with the presence of ACPA were associated with higher clinical severity of RA. CONCLUSIONS: The association among multiple risk variants related to T cell receptor signalling with seropositivity may play an important role in distinct clinical phenotypes of RA. Our study demonstrates that multiparametric analyses represent a powerful tool for investigation of mutual relationships of potential risk factors in complex diseases such as RA. Public Library of Science 2016-04-19 /pmc/articles/PMC4836711/ /pubmed/27092776 http://dx.doi.org/10.1371/journal.pone.0153316 Text en © 2016 Vernerova et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Vernerova, Lucia Spoutil, Frantisek Vlcek, Miroslav Krskova, Katarina Penesova, Adela Meskova, Milada Marko, Andrea Raslova, Katarina Vohnout, Branislav Rovensky, Jozef Killinger, Zdenko Jochmanova, Ivana Lazurova, Ivica Steiner, Guenter Smolen, Josef Imrich, Richard A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
title | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
title_full | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
title_fullStr | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
title_full_unstemmed | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
title_short | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
title_sort | combination of cd28 (rs1980422) and irf5 (rs10488631) polymorphisms is associated with seropositivity in rheumatoid arthritis: a case control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836711/ https://www.ncbi.nlm.nih.gov/pubmed/27092776 http://dx.doi.org/10.1371/journal.pone.0153316 |
work_keys_str_mv | AT vernerovalucia acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT spoutilfrantisek acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT vlcekmiroslav acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT krskovakatarina acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT penesovaadela acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT meskovamilada acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT markoandrea acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT raslovakatarina acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT vohnoutbranislav acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT rovenskyjozef acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT killingerzdenko acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT jochmanovaivana acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT lazurovaivica acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT steinerguenter acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT smolenjosef acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT imrichrichard acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT vernerovalucia combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT spoutilfrantisek combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT vlcekmiroslav combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT krskovakatarina combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT penesovaadela combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT meskovamilada combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT markoandrea combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT raslovakatarina combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT vohnoutbranislav combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT rovenskyjozef combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT killingerzdenko combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT jochmanovaivana combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT lazurovaivica combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT steinerguenter combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT smolenjosef combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy AT imrichrichard combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy |